Low-Dose Naltrexone (LDN): Uses Beyond Addiction
At its standard dose, naltrexone blocks opioid receptors and is used in addiction treatment. At roughly a tenth of that dose, it does something different and counterintuitive: a brief, partial receptor blockade that appears to upregulate the body’s own endorphins and calm certain inflammatory signaling. That’s the basis for its off-label use in chronic pain, fibromyalgia, and some autoimmune conditions.
The evidence is encouraging but still emerging, and LDN is generally well tolerated.
The same drug, a very different dose
Naltrexone is FDA-approved at around 50 mg to treat opioid and alcohol dependence by blocking opioid receptors. Low-dose naltrexone (LDN) typically means about 1.5 to 4.5 mg, a fraction of that. The dose is the whole story here: the low dose produces a short, partial blockade rather than a sustained one, and that brief interruption is thought to trigger a rebound increase in the body’s natural endorphins.
How LDN is thought to work
Two mechanisms are usually proposed. First, the endorphin rebound: by briefly blocking receptors, LDN may prompt the body to produce more of its own endorphins, which influence pain and mood. Second, an effect on glial cells in the nervous system, immune-like cells that, when overactive, drive inflammation and pain sensitization. LDN appears to quiet that overactivity. Both mechanisms point toward conditions involving pain and inflammation.
The off-label uses
- Fibromyalgia, among the most studied LDN applications, with small trials showing reduced pain for some patients.
- Chronic pain, particularly pain with an inflammatory or central-sensitization component.
- Autoimmune and inflammatory conditions, including reports in Crohn’s disease and multiple sclerosis-related symptoms.
- Fatigue and general inflammation, explored by some clinicians as part of a broader plan.
What the evidence actually says
This is the honest part. LDN has promising small studies and a lot of positive patient reports, but it lacks the large, definitive trials that move a treatment from “emerging” to “established.” For conditions like fibromyalgia the early data is genuinely interesting; for many other uses it’s more anecdotal. That doesn’t make it worthless, off-label medicine often runs ahead of large trials, but it means expectations should be measured and use should be supervised.
Side effects and tolerability
LDN is generally well tolerated, which is part of its appeal. The most common early side effects are vivid dreams or sleep disturbance and occasional headache, often easing with time or a dosing-time adjustment. The major hard rule: LDN is not compatible with opioid painkillers, since naltrexone blocks them, anyone using opioids must discuss this carefully with a prescriber.
A gentle option, properly dosed.
Because LDN requires precise low-dose compounding, sourcing matters. HermanRx connects you with licensed physicians who can assess fit and prescribe it through a US-licensed pharmacy.
Why dosing precision matters
Because LDN uses such small amounts, it’s typically compounded to the right strength rather than split from standard tablets. That makes the pharmacy and the prescriber central to getting it right. Telehealth platforms like HermanRx handle the evaluation and prescribe compounded LDN with the dosing precision it requires.
LDN is an unusual case: a cheap, well-tolerated, off-label option with a plausible mechanism and growing, if not yet definitive, evidence for pain and inflammatory conditions. If you live with fibromyalgia or chronic inflammatory pain and conventional options have fallen short, it’s a reasonable thing to discuss with a knowledgeable prescriber.
Frequently asked questions
How is LDN different from regular naltrexone?
It’s the same drug at roughly a tenth of the addiction-treatment dose. The low dose produces a brief, partial opioid-receptor blockade thought to raise the body’s own endorphins and calm inflammatory signaling.
What conditions is LDN used for?
Off-label, most commonly fibromyalgia and chronic inflammatory pain, with reports in autoimmune conditions like Crohn’s and MS-related symptoms. Evidence is strongest (though still small-scale) for fibromyalgia.
Can I take LDN with pain medication?
Not with opioid painkillers, naltrexone blocks them. This is a critical safety point to raise with your prescriber before starting.
Why does LDN need to be compounded?
The doses are very small and not available in standard tablets, so a compounding pharmacy prepares the exact strength. That’s why sourcing from a licensed provider matters.